A Phase 2 interventional study of Dentifrices in Gingival Inflammation and Bleeding and Dental Plaque, sponsored by Church & Dwight Company, Inc.. Completed at 1 site in Canada. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2021-08-23.
Sponsored by Church & Dwight Company, Inc. · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Gingivitis with a site in Canada — 1 open to participants now, 2 under way, none of them phase 3. Gingivitis · Canada.
Among the 22 studies in Gingivitis with a site in Canada, this one has the largest enrollment, is one of 3 that started in 2018, is one of 5 in phase 2, and was the 10th registered.
631 studies on the registry are indexed under Gingivitis; 107 are open to participants now.
Browse Gingivitis studies →1 of the 22 studies in Gingivitis with a site in Canada is open now. Recruiting first, the newest first:
Ostia Sciences · Sites in Canada
Ages 18–70
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 53 Gingivitis studies recruiting now, 15 (28%) set no upper age limit and 36 (68%) stop at 75 or younger; 11 take children under 18; 35 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 3 started in 2018.
This study's enrollment of 319 is above the median of 66 across 507 interventional studies indexed under Gingivitis.
Median enrollment 108 across the 22 interventional studies. Of the 20 that completed or were terminated, 5 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 22 have an industry lead sponsor. The 10 most frequent:
Church & Dwight Company, Inc. is the lead sponsor of 33 studies on the registry; none are open to participants now.
Church & Dwight Company, Inc. has 7 studies filed under Gingivitis — fewer than ten, so there is no comparison to draw.
2 of the studies in Gingivitis with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07256743Ostia SciencesEfficacy of SALI-10 Oral Probiotics in Experimental Gingivitis | 2026-12-31 |
| NCT07508839Ostia SciencesEvaluation of the Safety and Efficacy of SALI-10 Probiotic Lozenges | 2027-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 22 studies in Gingivitis with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Clinical study to evaluate and compare the efficacy of two baking soda containing dentifrices, containing 20% and 35% baking soda, to a non-baking soda dentifrice for their ability to reduce gingivitis and plaque following 6-months of use.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Dentifrices
Drug: Dentifrices
Drug: Dentifrices
Dentifrice on plaque, gingivitis, and bleeding.
Mean Within-Treatment Whole-Mouth Score - Gingival Efficacy
Mean Within-Treatment Whole-Mouth Score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.
Time frame: baseline, six weeks, 3 months and 6 months
Mean Within-Treatment Whole-Mouth Score - Gingival Bleeding Efficacy
Mean Within-Treatment Whole-Mouth Score as measured by Gingival Bleeding Index (0=absence of bleeding after 30 seconds, 1= bleeding observed after 30 seconds, 2= bleeding occurs instantly). The scale ranges from 0-2.
Time frame: baseline, six week, three months, and six months
Mean Within-Treatment Whole-Mouth Score - Plaque Efficacy
Mean Within-Treatment Whole-Mouth Score as measured by Plaque Index (0=no visible plaque, 1=separate flecks of plaque at the cervical margin of the tooth, 2=a thin, continuous band of plaque (up to 1mm wide) at the cervical margin, 3= a band of plaque wider than 1 mm but covering less than one-third of the crown, 4=plaque covering at least one-third but less than two-thirds of the crown, 5= plaque covering two-thirds or more of the crown). The scale ranges from 0-5.
Time frame: baseline, six weeks, three months, and six months
| Milestone | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice |
|---|---|---|---|
| Started | 104 | 107 | 108 |
| Completed | 103 | 105 | 107 |
| Not completed | 1 | 2 | 1 |
Mean Within-Treatment Whole-Mouth Score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.
| units on a scale | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice |
|---|---|---|---|
| Baseline | 2.081 ± 0.096 | 2.094 ± 0.117 | 2.092 ± 0.106 |
| 6 weeks | 1.996 ± 0.138 | 1.919 ± 0.171 | 1.882 ± 0.174 |
| 3 months | 1.980 ± 0.155 | 1.841 ± 0.198 | 1.766 ± 0.229 |
| 6 months | 1.946 ± 0.149 | 1.763 ± 0.209 | 1.653 ± 0.256 |
Mean Within-Treatment Whole-Mouth Score as measured by Gingival Bleeding Index (0=absence of bleeding after 30 seconds, 1= bleeding observed after 30 seconds, 2= bleeding occurs instantly). The scale ranges from 0-2.
| units on a scale | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice |
|---|---|---|---|
| Baseline | 0.165 ± 0.085 | 0.178 ± 0.129 | 0.189 ± 0.114 |
| 6 weeks | 0.149 ± 0.091 | 0.135 ± 0.122 | 0.122 ± 0.081 |
| 3 months | 0.141 ± 0.088 | 0.116 ± 0.117 | 0.094 ± 0.067 |
| 6 months | 0.129 ± 0.082 | 0.096 ± 0.104 | 0.069 ± 0.053 |
Mean Within-Treatment Whole-Mouth Score as measured by Plaque Index (0=no visible plaque, 1=separate flecks of plaque at the cervical margin of the tooth, 2=a thin, continuous band of plaque (up to 1mm wide) at the cervical margin, 3= a band of plaque wider than 1 mm but covering less than one-third of the crown, 4=plaque covering at least one-third but less than two-thirds of the crown, 5= plaque covering two-thirds or more of the crown). The scale ranges from 0-5.
| units on a scale | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice |
|---|---|---|---|
| Baseline | 2.409 ± 0.220 | 2.411 ± 0.244 | 2.356 ± 0.240 |
| 6 weeks | 2.280 ± 0.211 | 2.134 ± 0.259 | 2.026 ± 0.227 |
| 3 months 3 months | 2.251 ± 0.202 | 2.066 ± 0.260 | 1.907 ± 0.265 |
| 6 months | 2.196 ± 0.191 | 1.925 ± 0.239 | 1.793 ± 0.287 |
Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| 0% Baking Soda Dentifrice | 0/103 (0%) | 0/103 (0%) | 4/103 (3.9%) |
| 20% Baking Soda Dentifrice | 0/105 (0%) | 0/105 (0%) | 17/105 (16.2%) |
| 35% Baking Soda Dentifrice | 0/107 (0%) | 0/107 (0%) | 2/107 (1.9%) |
| Event | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice |
|---|---|---|---|
| Primary discomfortsGeneral disorders | 1/103 | 11/105 | 0/107 |
| Primary discomfortsGeneral disorders | 3/103 | 1/105 | 0/107 |
| Primary discomfortsGeneral disorders | 0/103 | 3/105 | 2/107 |
| Primary discomfortsGeneral disorders | 0/103 | 2/105 | 0/107 |
| Age, Continuous(Age) | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice | Total |
|---|---|---|---|---|
| Mean | 44.07 (18 to 70) | 47.50 (18 to 70) | 47.32 (18 to 70) | 46.3 (18 to 70) |
| Sex: Female, Male(Participants) | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice | Total |
|---|---|---|---|---|
| Female | 75 | 74 | 80 | 229 |
| Male | 28 | 31 | 27 | 86 |
| Race and Ethnicity Not Collected(Participants) | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice | Total |
|---|---|---|---|---|
| Count of participants | — | — | — | 0 |
| Region of Enrollment(participants) | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice | Total |
|---|---|---|---|---|
| Canada | 103 | 105 | 107 | 315 |
| Gingvial Efficacy(units on a scale) | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice | Total |
|---|---|---|---|---|
| Mean | 2.081 (0 to 4) | 2.094 (0 to 4) | 2.092 (0 to 4) | 2.089 (0 to 4) |
| Gingival Bleeding Efficacy(units on a scale) | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice | Total |
|---|---|---|---|---|
| Mean | 0.165 (0 to 2) | 0.178 (0 to 2) | 0.189 (0 to 2) | 0.177 (0 to 2) |
| Plaque Efficacy(units on a scale) | 0% Baking Soda Dentifrice | 20% Baking Soda Dentifrice | 35% Baking Soda Dentifrice | Total |
|---|---|---|---|---|
| Mean | 2.409 (0 to 5) | 2.411 (0 to 5) | 2.356 (0 to 5) | 2.4 (0 to 5) |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Feb 2018 to primary completion in Aug 2018, 6 months.
Results were first posted in Aug 2021, 2 years 11 months after primary completion.
Of 16 phase 2 interventional studies under Gingivitis, half reached primary completion within 2 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 15. This study's 6 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Dentifrices
Church & Dwight Company, Inc. →